Login / Signup

Another milestone in the evolution of GLP-1-based diabetes therapies.

Michael A NauckDaniel Robert QuastJuris J Meier
Published in: Nature medicine (2021)
Keyphrases
  • type diabetes
  • cardiovascular disease
  • glycemic control
  • metabolic syndrome
  • insulin resistance